Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/108813
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Hochhaus, Andreas |
dc.contributor.author | Larson, Richard A. |
dc.contributor.author | Guilhot, François |
dc.contributor.author | Radich, Jerald P. |
dc.contributor.author | Branford, Susan |
dc.contributor.author | Hughes, Timothy P. |
dc.contributor.author | Baccarani, Michele |
dc.contributor.author | Deininger, Michael W. |
dc.contributor.author | Cervantes Requena, F. |
dc.contributor.author | Fujihara, Satoko |
dc.contributor.author | Ortmann, Christine E. |
dc.contributor.author | Menssen, Hans D. |
dc.contributor.author | Kantarjian, Hagop M. |
dc.contributor.author | O'Brien, Stephen G. |
dc.contributor.author | Druker, Brian J. |
dc.date | 2017-03-22T15:59:34Z |
dc.date | 2017-09-09T22:01:26Z |
dc.date | 2017-03-09 |
dc.date | 2017-03-22T15:59:34Z |
dc.identifier.citation | 0028-4793 |
dc.identifier.citation | 669609 |
dc.identifier.uri | http://hdl.handle.net/2445/108813 |
dc.format | 11 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Massachusetts Medical Society |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1056/NEJMoa1609324 |
dc.relation | New England Journal of Medicine, 2017, vol. 376, num. 10, p. 917-927 |
dc.relation | https://doi.org/10.1056/NEJMoa1609324 |
dc.rights | (c) Massachusetts Medical Society, 2017 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Leucèmia mieloide |
dc.subject | Inhibidors enzimàtics |
dc.subject | Hematologia |
dc.subject | Myeloid leukemia |
dc.subject | Enzyme inhibitors |
dc.subject | Hematology |
dc.title | Long-term outcomes of imatinib treatment for chronic myeloid leukemia. |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |